Emrah Kaygusuz | Genetics | Research Excellence Award

Published on by Molecular Biologist

Assist. Prof. Dr. Emrah Kaygusuz | Genetics | Research Excellence Award 

Assistant Professor | Institute of Human Genetics at the University Medical Center Göttingen | Germany

Asst. Prof. Emrah Kaygusuz is a molecular biologist and geneticist with strong international research experience in human genetics, genomics, and rare hereditary disorders. His work combines molecular biology and bioinformatics to uncover disease-causing mechanisms underlying neurodevelopmental, craniofacial, and genetic syndromes. He has produced a focused body of high-quality scholarly output, contributing 7 peer-reviewed documents that have received 113 citations across 105 citing publications, reflecting steady academic influence with an h-index of 5. His research achievements are supported by competitive funding, recognized through prestigious scientific awards, and strengthened by invited scientific presentations and peer-review activities, demonstrating consistent excellence and impact suitable for award nomination.

Citation Metrics (Scopus)

120

100

80

60

40

20

0

Citations
113

Documents
7

h-index
5

        🟦 Citations    🟥 Documents    🟩 h-index


View Scopus Author Profile

Rasime Kalkan | Genetics | Best Researcher Award

Published on by Molecular Biologist

Prof. Dr. Rasime Kalkan | Genetics | Best Researcher Award 

Prof. Dr. Rasime Kalkan | European University of Lefke | Cyprus

Prof. Dr. Rasime Kalkan has earned widespread recognition for her exceptional contributions to medical genetics, molecular biology, and academic leadership. She serves as Editor and Guest Editor for prestigious journals such as Frontiers in Bioengineering and Biotechnology, Frontiers in Epigenetics and Epigenomics, and Springer Nature’s series Epigenetics and Human Health and Stem Cell Biology and Regenerative Medicine. Her editorial achievements include editing influential books such as Cancer Epigenetics, Molecular Mechanisms in Nutritional Epigenetics, and miRNAs, Human Health and Diseases (Springer Nature). Throughout her career, she has been invited to deliver keynote lectures at international conferences, recognized for advancing translational genetics and biomedical innovation. Prof. Kalkan has supervised numerous award-winning theses and inspired a generation of researchers in molecular epigenetics and regenerative medicine. Her outstanding academic service, research leadership, and dedication to mentoring exemplify excellence in modern biomedical science, positioning her as a leading figure in molecular genetics and personalized medicine.

Profile: ORCID | Google Scholar

Featured Publications

Kalkan, R. IDH1 mutations as prognostic marker for Glioblastoma Multiforme. Gene. Cited by 220.

Kalkan, R. Epigenetics of Glioblastoma Multiforme. Journal of Clinical Research & Bioethics (J Clin Res Bioeth). Cited by 185.

Kalkan, R. miRNAs in Glioblastoma Progression and Prognosis. Critical Reviews in Eukaryotic Gene Expression (Crit Rev Eukaryot Gene Expr). Cited by 110.

Kalkan, R. RANK/RANKL/OPG pathway in epigenetic regulation of obesity. Molecular Biology Reports (Mol Biol Rep). Cited by 92.

Kalkan, R. DNA methylation of circadian rhythm genes and obesity. Biochemical Genetics (Biochem Genet). Cited by 15.

Hyo Jin Yoon | Genetics | Best Researcher Award

Published on by Molecular Biologist

Ms. Hyo Jin Yoon | Genetics | Best Researcher Award 

Clinical Laboratory Scientist, Staff member, at National Radiation Emergency Medical Center, Korea Institute of Radiological & Medical Sciences (KIRAMS), South Korea.

Hyo Jin Yoon is an accomplished Clinical Laboratory Scientist with over 15 years of expertise in cytogenetics and biological dosimetry. Based at the National Radiation Emergency Medical Center, Korea Institute of Radiological & Medical Sciences (KIRAMS), she plays a pivotal role in advancing diagnostic and emergency response strategies in radiation exposure cases. Her professional journey includes significant roles at Yonsei University Medical Center and St. Mary’s Hospital. She has been instrumental in developing DiCADE, an AI-driven software for dicentric chromosome analysis, enhancing the accuracy and speed of biodosimetric assessments. A certified ASCPi-IMLT professional, she also serves as a KOLAS Technical Expert for ISO 15189. Through her multidisciplinary approach combining clinical practice, research, and innovation, Hyo Jin continues to elevate global standards in radiation emergency medicine. 🌍🧪💡

Professional Profile

Scopus

🎓 Education 

Hyo Jin began her academic journey in clinical pathology by earning an associate degree from Daejeon Health College, which laid a strong foundation in laboratory sciences. She furthered her education at Eulji University, completing bachelor’s-level coursework with a specialization in medical laboratory technology. Her dedication to professional growth led her to earn the prestigious ASCPi-IMLT certification in 2012, an internationally recognized credential in medical laboratory science. Her continuous pursuit of learning has enabled her to integrate traditional laboratory practices with modern innovations in AI-based diagnostics. 📚👩‍🔬🎓

💼 Experience 

With a distinguished career spanning over 15 years, Hyo Jin Yoon has made significant contributions across clinical, academic, and research domains. She began her professional tenure at Yonsei University Medical Center and later at St. Mary’s Hospital, gaining frontline diagnostic experience in clinical pathology. Since 2015, she has been a core member of the Laboratory of Biodosimetry at KIRAMS-NREME, where she is actively engaged in radiation biodosimetry, diagnostics, and AI-integrated tool development. Her practical insights have been crucial in enhancing laboratory standards and emergency response protocols in radiation medicine. Additionally, as a KOLAS Technical Expert (ISO 15189), she ensures quality and compliance in laboratory operations. 🏥🧬🛡️

🔬 Research Interest

Hyo Jin’s research interests lie at the intersection of cytogenetics, radiation biodosimetry, and medical AI applications. Her core focus is on developing diagnostic tools that improve the biological dose assessment of radiation exposure, particularly during emergencies. Her innovative work on DiCADE—a semi-automated AI-powered dicentric chromosome analysis system—demonstrates her commitment to precision diagnostics. She is deeply involved in international collaboration networks such as RENEB and works with partners like Health Canada and Hirosaki University. Her current research also involves harmonizing scoring standards for cytogenetic assays across biodosimetry networks in South Korea. Her interdisciplinary interests aim to make radiation response faster, more accurate, and globally standardized. 🤖🔎📈

🏆 Awards & Recognitions 

Hyo Jin Yoon’s pioneering work in the field of radiation biodosimetry has earned her respect and recognition across scientific communities. In addition to securing a software copyright for DiCADE (Reg. No. C-2025-019817, dated May 27, 2025), she also has a pending trademark for the tool. As a certified KOLAS Technical Expert, she has contributed to national laboratory quality assurance initiatives. Her participation in international intercomparison exercises with RENEB and Health Canada further reflects her global outreach and credibility. She is a consistent contributor to academic conferences and technical exchange programs, and her work is regarded as a benchmark in South Korea’s preparedness for radiation emergencies. 🥇🔬📜

📚 Top Noted Publications

Hyo Jin Yoon has co-authored six peer-reviewed articles, significantly advancing the field of biological dosimetry:

1. Collaborative Activities in a Biological Dosimetry Network for Radiation Emergencies in South Korea

  • Journal: International Journal of Radiation Biology, 2025

  • Citations: 7

  • Summary:
    This paper presents the establishment and development of a coordinated biological dosimetry network in South Korea. It focuses on preparedness strategies for radiation emergencies, inter-laboratory collaboration, and standardization of methodologies across partner institutions. The paper emphasizes international alignment with IAEA and WHO guidelines and proposes protocols for emergency biodosimetry response.

  • Key Contributions:

    • Strengthens Korea’s radiation emergency response infrastructure.

    • Highlights the importance of capacity building and shared resources.

    • Demonstrates real-case simulations for readiness evaluation.

2. Lessons on Harmonization of Scoring Criteria for Dicentric Chromosome Assay in South Korea

  • Journal: International Journal of Radiation Biology, 2024

  • Citations: 5

  • Summary:
    This study reports on efforts to unify scoring criteria among Korean biodosimetry laboratories for the dicentric chromosome assay (DCA), a key cytogenetic tool in radiation dose assessment. It compares results across labs and discusses discrepancies and consensus-building.

  • Key Contributions:

    • Establishes baseline standards for DCA scoring nationwide.

    • Recommends training protocols and QA practices.

    • Encourages future harmonization with global networks.

3. Application of a Semi-Automated Dicentric Scoring System in Triage and Monitoring Occupational Radiation Exposure

  • Journal: Frontiers in Public Health, 2024

  • Citations: 6

  • Summary:
    This paper evaluates a semi-automated image analysis platform for scoring dicentric chromosomes in metaphase cells. Its application for radiation triage and occupational health surveillance is assessed, showing increased speed and reproducibility.

  • Key Contributions:

    • Reduces manual workload and inter-scorer variability.

    • Supports large-scale triage in radiation emergencies.

    • Offers a model for integrating AI-assisted analysis in routine monitoring.

4. Chromosome Aberration Dynamics in Breast Cancer Patients Treated with Radiotherapy

  • Journal: Mutation Research, 2023

  • Citations: 10

  • Summary:
    This study tracks the temporal profile of chromosome aberrations, including dicentrics and translocations, in breast cancer patients undergoing radiotherapy. It assesses the persistence of aberrations post-treatment as a biomarker of cumulative exposure.

  • Key Contributions:

    • Reveals individual variation in chromosomal response to radiotherapy.

    • Proposes implications for patient-specific radiation sensitivity.

    • Highlights the utility of cytogenetics in post-therapy surveillance.

5. An Intercomparison Exercise to Compare Scoring Criteria and Develop Image Databank for Biodosimetry in South Korea

  • Journal: International Journal of Radiation Biology, 2023

  • Citations: 4

  • Summary:
    This paper documents an inter-laboratory comparison in which multiple Korean institutions scored the same set of metaphase images to assess consistency. It led to the creation of a national image databank to support training and harmonization.

  • Key Contributions:

    • Identifies scoring variability and proposes mitigation strategies.

    • Establishes a digital resource for future reference and QA.

    • Supports IAEA-compliant training infrastructure.

6. Effective Centrifugation Techniques for Improving Metaphase Spreads in Lymphocytopenic Patients

  • Journal: International Journal of Radiation Biology, 2022

  • Citations: 3

  • Summary:
    This methodological paper explores optimized centrifugation protocols to enhance metaphase yield in samples with low lymphocyte counts, such as from immunocompromised or radiotherapy-treated individuals.

  • Key Contributions:

    • Offers practical improvements to sample preparation protocols.

    • Increases metaphase cell quality and scoring accuracy.

    • Beneficial for labs working with difficult patient samples.

Conclusion

Hyo Jin, Yoon demonstrates exceptional dedication to scientific advancement in the field of biological dosimetry, combining clinical excellence with innovative research. Her work in developing AI-driven diagnostic tools and her collaborative efforts in national and international radiation emergency networks make her a highly suitable candidate for the Best Researcher Award. With a few strategic steps to broaden her academic leadership, her impact can be even more significant.

Ahmed Khedr | Genetics | Excellence in Research

Published on by Molecular Biologist

Assist. Prof. Dr. Ahmed Khedr | Genetics | Excellence in Research 

Assistant Professor Doctorate, at Faculty of Medicine, Helwan University, Egypt.

✨ Ahmed MB Khedr is an accomplished medical biochemist and molecular biologist, currently serving as a Lecturer (Assistant Professor) at the Faculty of Medicine, Helwan University. His research focuses on the role of microRNAs and long non-coding RNAs in systemic and autoimmune diseases, particularly multiple sclerosis and systemic sclerosis. With a strong academic foundation and extensive teaching experience, he has contributed significantly to the fields of molecular biology and clinical biochemistry. Dr. Khedr has also been an active reviewer for renowned journals and has several peer-reviewed publications to his credit. His dedication to medical research and education has earned him recognition in academia and beyond.

Professional Profile

Scopus

Education 🎓

Dr. Ahmed MB Khedr holds a Ph.D. in Medical Biochemistry and Molecular Biology from Cairo University (2023), where he investigated MiRNA-133 and lncRNA-H19 expressions in systemic sclerosis patients. He earned his MSc from Cairo University (2020), focusing on the relationship between MiRNA-22, vitamin D, and its receptor in multiple sclerosis patients. His academic journey began with a Bachelor of Medicine and Surgery (MBBCH) from Benha University in 2014. His education has provided him with a robust background in medical biochemistry, equipping him with the expertise to advance research in molecular diagnostics and disease pathogenesis.

Experience 🌟

Dr. Khedr has over eight years of academic and clinical experience. He has been a Lecturer at Batterjee Medical College since 2023 and previously served as an Assistant Lecturer at Helwan University from 2020 to 2023. He also worked as a Demonstrator at Helwan University (2017-2020), a General Practitioner at the Ministry of Health in Egypt (2016-2017), and a House Officer at Benha University Hospitals (2015-2016). Throughout his career, he has taught medical biochemistry to students across various faculties, including medicine, physical therapy, nursing, and allied health sciences, while also coordinating laboratory courses and exams.

Research Interests 📝

Dr. Khedr’s research is centered on molecular mechanisms underlying systemic diseases. His primary focus is on microRNAs and long non-coding RNAs in autoimmune and neurological disorders such as systemic sclerosis and multiple sclerosis. His work explores the diagnostic and prognostic potential of these biomarkers in disease progression. Additionally, he investigates biochemical pathways linked to vitamin D metabolism, oxidative stress, and inflammatory signaling. His contributions aim to enhance molecular diagnostics and therapeutic strategies for complex diseases.

Awards & Recognition 🏆

Dr. Khedr has received multiple awards and recognitions for his academic contributions. In February 2019, he was awarded an Appreciation Certificate for his participation in the Quality Assurance and Accreditation Unit and community services at Helwan University. In January 2019, he was recognized as a qualified member of the First Aid Workshop at the Faculty of Medicine, Helwan University. His dedication to academic excellence and community service has positioned him as a key figure in medical education and research.

Top Notes Publications 📚

  • Khedr et al. (2024)
    • Title: MiRNA-133 and lncRNA-H19 expressions and their relation to serum levels of PKM2 and TGF-β in patients with systemic sclerosis.
    • Journal: Non-Coding RNA Research
    • Key Findings:
      • Investigates the expression levels of MiRNA-133 and lncRNA-H19 in systemic sclerosis patients.
      • Analyzes their correlation with serum PKM2 (pyruvate kinase M2) and TGF-β (Transforming Growth Factor-beta).
      • Findings suggest potential biomarkers for systemic sclerosis.
    • DOI: 10.1016/j.ncrna.2023.12.003
  • Mohamad et al. (2023)
    • Title: Expression of Long Noncoding RNA, HOTAIR, and MicroRNA-205 and Their Relation to Transforming Growth Factor β1 in Patients with Alopecia Areata.
    • Journal: Skin Appendage Disorders
    • Key Findings:
      • Examines the role of HOTAIR (lncRNA) and miRNA-205 in alopecia areata.
      • Explores their relationship with TGF-β1, which plays a role in immune response and hair follicle cycling.
      • Suggests that these ncRNAs may be involved in the pathogenesis of alopecia areata.
    • DOI: 10.1159/000527851
  • Khedr et al. (2022)
    • Title: MicroRNA-22 Level in Patients with Multiple Sclerosis and Its Relationship with Vitamin D and Vitamin D Receptor Levels.
    • Journal: Neuroimmunomodulation
    • Key Findings:
      • Investigates miRNA-22 levels in multiple sclerosis (MS) patients.
      • Studies its correlation with Vitamin D and Vitamin D receptor (VDR) levels.
      • Findings indicate a potential regulatory role of miRNA-22 in MS progression and Vitamin D metabolism.
    • DOI: 10.1159/000519012

Conclusion

Dr. Ahmed MB Khedr is a strong candidate for Research for Excellence in Research due to his solid academic background, research expertise, peer-review contributions, and teaching experience. To further enhance his competitiveness, he should focus on increasing high-impact publications, securing grants, expanding collaborations, and gaining more international recognition. With continued research advancements, he has significant potential to achieve excellence in his field.